Real-world treatment utilization in adults with chronic inflammatory demyelinating polyneuropathy in the United States
Steroids and Ig were mainstay treatments among patients with CIDP. A substantial proportion of Ig users were chronic users who also received other CIDP therapies, with steroids being most common. This suggests a potentially pronounced burden among patients treated with frequent Ig and steroids.
Authors
- Hashmath Ulla Syed
- C. Blein (ORCID: https://orcid.org/0000-0003-0900-8351)
- Chafic Karam
- Deborah E. Gelinas
- C Arvin-Berod
- Amit Goyal (ORCID: https://orcid.org/0000-0002-5427-7852)
- Sergio Barrera-Sierra Barrera-Sierra
- Charlotte E. Ward (ORCID: https://orcid.org/0000-0003-4877-8412)
- Jeffrey T. Guptill
Institutions
- Argenx (Belgium) (BE)
- University of Pennsylvania (US)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2026-01-29
- DOI
- https://doi.org/10.3389/fneur.2025.1726857
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Argenx